Should I sell my 3 favourite UK growth stocks and buy my 3 worst performers?

Harvey Jones is wondering whether to take the profits on his three most successful growth stocks, and plough the money back into his three biggest flops.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young woman holding up three fingers

Image source: Getty Images

I buy FTSE growth shares with the aim of holding through thick and thin, to give them time to realise their full potential. But is this the right strategy?

Instead of buying and holding, a different school of thought suggests investors sell their winners every year or so, and reinvest their gains in some of their worst performers.

This works on the assumption that stock performance is cyclical. Successful stocks tend to be expensive, poor performers cheaper. Selling high and buying low is every investor’s dream, isn’t it?

Time to buy, hold or sell?

Also, success tends to come in waves. I’ve seen this with my three best performers over the last year: private equity specialist 3i Group, insurer Just Group and outsourcer Costain Group.

As my table shows, they’ve had a brilliant run lately. I also suspect they may struggle to maintain their momentum.


One monthOne yearTwo yearsFive years
3i Group5.87%64.54%183.04%198.04%
Just Group0.14%106.1%118.83%155.5%
Costain Group-2.87%80.6%153.75%-35.51%

My three worst performers have had a dismal few years.


One monthOne yearTwo yearsFive years
Burberry Group4.3%-64.22%-66.01 %-68.14%
Aston Martin-27.43%-58.47%-83.39%-96.94%
GSK-12.29%-1.84%9.87%-16.03%

The longest I’ve held any of these stocks is just 15 months. So luckily I haven’t lost 96.94% of my original stake, as I would have done if I’d bought Aston Martin Lagonda (LSE: AML) five years ago. At the same time, I’m not sitting on a 198.04% gain, as I would with 3i Group.

I only bought Aston Martin a month ago, and I’m already down 30%. I rarely put money into highly volatile stocks like this one. Basically, I had a small amount of cash left in my portfolio, and decided to have a flutter.

I knew what I was getting into. On 20 September I wrote that “Aston Martin makes sleek luxury cars but as an investment it’s been a wheezing old banger”, going bust seven times since it was set up in 1913.

Investing is a long-term game

I took a chance because the group is in transition mode, as it lines up its Vantage luxury supercar and upgraded DBX707 models. It had also just appointed a new CEO in Adrian Hallmark, fresh from a successful stint at Bentley Motors. I thought that might bode well. I was wrong.

On 30 September the board set it was likely to miss full-year targets, blaming supply chain delays and weak Chinese demand.

I’m certainly not selling any of my three winners to double down on Aston Martin. Shares in 3i Group, Just and Costain have idled in recent weeks, but I still see them as a better way to build long-term wealth.

I’m not buying more GSK either. Its short-term future rests on a string of US legal claims over discontinued heartburn medication Zantac. Before doing anything, I’ll wait for those to be settled. As for Burberry, I’ve thrown more than enough cash at that falling knife.

I think five of these six stocks will prove their worth over the longer run. Aston Martin is the wildcard. I shouldn’t have got involved, but don’t see much point selling now. So it’s still buy-and-hold all the way for me.

Harvey Jones has positions in 3i Group Plc, Aston Martin, Burberry Group Plc, Costain Group Plc, GSK, and Just Group Plc. The Motley Fool UK has recommended Burberry Group Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »